This is a demo store. No orders will be fulfilled.
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
10 Apr 2019  |  Africa  |  Market Research
Generic Pharmaceutical Market in Kenya and Nigeria, Forecast to 2022
Greater Regulatory Control and a Shift of Focus Away from Costly and Branded Drugs will Increase Generic Drugs’ Market Share
The African continent grapples with a huge burden of communicable diseases, particularly HIV/AIDS, tuberculosis, and malaria. With African governments facing major health financing challenges, a significant proportion of these disease areas are financed by global aid organizations that are also helping in poverty eradication in the continent. Paral...
$3,000.00 -
13 Dec 2018  |  Africa  |  Market Research
Healthcare Regulatory Environment in Nigeria and Ghana, 2018
Unlocking Investment Potential and Improving Healthcare Delivery and Access through Policy Advancement
The West African region has a handful of emerging economies within Sub-Saharan Africa in terms of overall development and growth. The region currently has a high number of people living in extreme poverty, particularly in Nigeria, as well as a high population density. Furthermore, there has been a growing trend of non-communicable diseases, such as...
$1,500.00 -
30 Oct 2018  |  Africa  |  Market Research
Healthcare Regulatory Environment in Kenya, Tanzania, and Ethiopia, 2018
Unlocking Investment Potential and Improving Healthcare Delivery and Access through Policy Advancement
The East African region boasts of a number of emerging leaders within Sub-Saharan Africa in terms of overall development and growth. On one hand, the region has one of the highest burdens of disease in the world, such as HIV, malaria, and tuberculosis. On the other hand, there has been a growing trend of non-communicable diseases, such as cancers a...
$1,500.00 -
06 Nov 2017  |  South Asia, Middle East & North Africa  |  Market Research
Growth and Investment Opportunities in Nepal Healthcare Market, 2017
Incidence of Non-Communicable Diseases increasing leading to demand for specialty services
This industry docket assess Nepal's healthcare market and highlights investment opportunities therein. The country lacks centers of excellence in tertiary care leading to outflow of patients seeking the same. Nepal is currently seeing increasing investment by private and corporate hospital sectors in speciality services like Cardiac Sciences, Neu...
$1,500.00 -
21 Dec 2016  |  Africa  |  Market Research
African Pharmaceuticals Market, Forecast to 2020
Assessing Market Potential with a Focus on Kenya and Nigeria
The pharmaceuticals market in Africa is expected to reach a business opportunity of $45 billion in 2020, propelled by a convergence of changing economic profiles, rapid urbanisation, increased healthcare spending and investment, and increasing incidence of chronic lifestyle diseases. The tropical climate of Africa makes the continent the largest re...
$4,950.00 -
27 May 2016  |  Africa  |  Market Research
Pharmaceutical Market Access Strategy for Ethiopia
Landscaping New Investment Opportunities Across the Pharmaceutical Value Chain
Scope of the report The research report includes the following segments: Product scope: Pharmaceutical Products Geographic scope: Ethiopia End-user scope: Pharmaceutical manufacturers, Pharmaceutical distributors, Healthcare providers, Contract Manufacturing Organisations (CMO) Revenue analysis and forecasts, drivers and restraints, business opp...
$4,950.00 -
17 May 2016  |  Africa  |  Market Research
East African Knee and Hip Replacement Products Markets, Forecast to 2020
Demographic and Economic Changes Spark New, High-Growth Investment Opportunities
The study analyses the East African joint replacement market to establish the current operating environment and market dynamics. Furthermore, this research service analyses the drivers, restraints, and reimbursement scenario, and scrutinizes relevant upcoming projects. The research methodology of this study is based on primary interviews and second...
$4,950.00 -
11 Dec 2015  |  South Asia, Middle East & North Africa  |  Market Research
Impact of Lifting Nuclear Sanctions on Iran’s Healthcare Market—Now and Later
The Lifting of Nuclear Sanctions on Iran will open a Plethora of Opportunities in the Medical Tourism and Pharmaceutical Sectors
Several international sanctions were imposed over Iran over the last decade, restraining its international trade capacity. Yet, Iran is the 17th largest economy in the world; its Gross Domestic Product (GDP) was $415.3 billion in 2014. The nuclear sanctions imposed by the United Nations on Iran resulted in trade bans and restrictions on financial t...
$1,500.00 -
03 Aug 2015  |  Africa  |  Market Research
China Contract Research Organisation Market
Exploring the Market Landscape and Future Opportunities
The pharmaceutical industry in Ghana and Nigeria is forecast to represent a combined business opportunity of over $3 billion by 2018, propelled by a convergence of changing economic profiles, increased healthcare spending and investment, and increasing incidence of chronic diseases. Market segmentation is done based on products (OTC, generic, and b...
$1,500.00 -
09 Apr 2015  |  South Asia, Middle East & North Africa  |  Market Research
Global Haemophilia Therapeutics Market
Increased use of recombinant and prophylaxis therapies drives growth
This research service studies the Indian Diabetes market. It provides the number of Type 1 and Type 2 diabetic patients in India across different age groups and forecasts these numbers up to 2030. It provides a detailed analysis of the two major segments of the market, the insulin market segment and the anti-diabetic medications segment, which incl...
$3,950.00